Savara announces new employment inducement grant

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. on february 12, 2025, the compensation committee of savara's board of directors granted the inducement awards to five new employees who recently joined the company. the inducement awards consist of options to purchase an aggregate of 97,500 shares of the company's common stock and restr.
SVRA Ratings Summary
SVRA Quant Ranking